Qianwei Xing

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Immune Response

Prostate Cancer

Long Noncoding Rna

Top Venues

Cancer cell international

European journal of immunology

BioMed research international

World journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yi Wang, Hao Ji, Bingye Zhu, Qianwei Xing, Huyang Xie
Molecular subtypes based on metabolic genes are potential biomarkers for predicting prognosis and immune responses of clear cell renal cell carcinoma. European journal of immunology (2022)
Yi Wang, Shouyong Liu, Yinhao Chen, Bingye Zhu, Qianwei Xing
Survival Prognosis, Tumor Immune Landscape, and Immune Responses of PPP1R18 in Kidney Renal Clear Cell Carcinoma and Its Potentially Double Mechanisms. World journal of oncology 13 (1) (2022)
Yi Wang, Rong Cong, Shouyong Liu, Bingye Zhu, Xing Wang, Qianwei Xing
Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma. Cancer cell international 21 (1) (2021)
Yi Wang, Ye Tian, Shouyong Liu, Zengjun Wang, Qianwei Xing
Prognostic value and immunological role of AXL gene in clear cell renal cell carcinoma associated with identifying LncRNA/RBP/AXL mRNA networks. Cancer cell international 21 (1) (2021)
Qianwei Xing, Huyang Xie, Bingye Zhu, Zhiwei Sun, Ye-Qing Huang
MiR-455-5p Suppresses the Progression of Prostate Cancer by Targeting CCR5. BioMed research international 2019 (2019)